Biography

Dr. Cheryl Blume received her Ph.D. in Pharmacology and Toxicology from The West Virginia University Medical Center. Dr. Blume then worked in the U.S. pharmaceutical industry and held the executive positions of VP, Scientific Affairs (Mylan Laboratories) and Executive VP and COO (Somerset Pharmaceuticals). She has participated in over 100 ANDAs/NDAs and many IND research programs. Dr. Blume has testified before Congress, is the inventor of multiple U.S. and international patents, and is an author of peer reviewed articles. As the Founder and President of Pharmaceutical Development Group (PDG), Dr. Blume now assists FDA regulated, U.S. and international companies in the navigation of U.S. procedures. This spans a variety of product forms and therapeutic areas, including prescription and non-prescription drugs and medical devices. Dr. Blume is also an Affiliate Associate Professor to the Voluntary Faculty, Department of Molecular Pharmacology & Physiology, University of South Florida, Tampa, Florida